title: The cancer secretome: a reservoir of biomarkers.
abstract: Biomarkers are pivotal for cancer detection, diagnosis, prognosis and therapeutic monitoring. However, currently available cancer biomarkers have the disadvantage of lacking specificity and/or sensitivity. Developing effective cancer biomarkers becomes a pressing and permanent need. The cancer secretome, the totality of proteins released by cancer cells or tissues, provides useful tools for the discovery of novel biomarkers. The focus of this article is to review the recent advances in cancer secretome analysis. We aim to elaborate the approaches currently employed for cancer secretome studies, as well as its applications in the identification of biomarkers and the clarification of carcinogenesis mechanisms. Challenges encountered in this newly emerging field, including sample preparation, in vivo secretome analysis and biomarker validation, are also discussed. Further improvements on strategies and technologies will continue to drive forward cancer secretome research and enable development of a wealth of clinically valuable cancer biomarkers.
authors.affiliation: Department of Pathology, School of Medicine, Zhejiang University, PR China. snowhh@163.com
authors.forename: Hua
authors.initials: H
authors.lastname: Xue
authors.forename: Bingjian
authors.initials: B
authors.lastname: Lu
authors.forename: Maode
authors.initials: M
authors.lastname: Lai
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000378:metabolism*; D016678:Genome; D006801:Humans; D009369:Neoplasms / Q000378:metabolism*; D040901:Proteomics
chemical_list: D014408:Biomarkers, Tumor
references.citation: Mol Cell Proteomics. 2003 May;2(5):299-314
references.pmid: 12766231
references.citation: Proteomics. 2006 Aug;6(15):4381-9
references.pmid: 16819731
references.citation: Expert Rev Proteomics. 2004 Dec;1(4):401-9
references.pmid: 15966837
references.citation: Brief Funct Genomic Proteomic. 2004 Nov;3(3):280-6
references.pmid: 15642190
references.citation: Proteomics. 2005 Jan;5(1):307-17
references.pmid: 15619298
references.citation: Proteomics. 2008 Jan;8(2):316-32
references.pmid: 18203259
references.citation: J Am Soc Mass Spectrom. 2005 Aug;16(8):1207-20
references.pmid: 15979338
references.citation: Anal Chem. 2003 Oct 1;75(19):5054-61
references.pmid: 14708778
references.citation: Proteomics. 2005 Jul;5(10):2587-601
references.pmid: 15912508
references.citation: Proteomics. 2007 Jun;7(11):1757-70
references.pmid: 17464941
references.citation: Lung Cancer. 2006 Oct;54(1):87-94
references.pmid: 16876904
references.citation: Cancer Res. 2006 Feb 1;66(3):1376-83
references.pmid: 16452192
references.citation: Proteomics. 2005 Aug;5(13):3304-13
references.pmid: 16052628
references.citation: Exp Biol Med (Maywood). 2008 Jun;233(6):708-20
references.pmid: 18408141
references.citation: Mol Cell Proteomics. 2004 Apr;3(4):327-44
references.pmid: 14754989
references.citation: Proteomics. 2006 Dec;6(23):6326-53
references.pmid: 17083142
references.citation: Clin Chem. 2008 Mar;54(3):574-81
references.pmid: 18202161
references.citation: Pathol Res Pract. 2004;200(2):83-94
references.pmid: 15237917
references.citation: Cancer Lett. 2002 May 8;179(1):1-14
references.pmid: 11880176
references.citation: Clin Cancer Res. 2008 May 1;14(9):2579-87
references.pmid: 18451219
references.citation: Cancer Res. 2004 Jan 1;64(1):347-55
references.pmid: 14729644
references.citation: Minerva Urol Nefrol. 2008 Mar;60(1):51-60
references.pmid: 18427435
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13537-42
references.pmid: 14573703
references.citation: Biochemistry (Mosc). 2006 Oct;71(10):1060-72
references.pmid: 17125453
references.citation: J Physiol. 2005 Feb 15;563(Pt 1):23-60
references.pmid: 15611012
references.citation: J Proteome Res. 2008 Sep;7(9):3765-75
references.pmid: 18646789
references.citation: J Proteome Res. 2006 Oct;5(10):2861-4
references.pmid: 17022658
references.citation: J Cancer Res Clin Oncol. 2008 Jul;134(7):769-76
references.pmid: 18202856
references.citation: J Proteome Res. 2007 Mar;6(3):1083-92
references.pmid: 17284061
references.citation: Future Oncol. 2005 Feb;1(1):37-50
references.pmid: 16555974
references.citation: Electrophoresis. 1996 Jul;17(7):1265-72
references.pmid: 8855415
references.citation: J Proteome Res. 2004 May-Jun;3(3):469-77
references.pmid: 15253428
references.citation: Proteomics. 2005 Aug;5(13):3292-303
references.pmid: 16052620
references.citation: Microbiol Mol Biol Rev. 2000 Sep;64(3):515-47
references.pmid: 10974125
references.citation: J Proteome Res. 2005 Sep-Oct;4(5):1722-31
references.pmid: 16212426
references.citation: J Proteome Res. 2006 Apr;5(4):899-906
references.pmid: 16602697
references.citation: Mol Cell Proteomics. 2005 Oct;4(10):1480-6
references.pmid: 15970581
references.citation: Proteomics. 2004 Apr;4(4):1175-86
references.pmid: 15048997
references.citation: J Proteome Res. 2002 Jan-Feb;1(1):47-54
references.pmid: 12643526
references.citation: J Natl Cancer Inst. 2004 Sep 15;96(18):1356-7
references.pmid: 15367567
references.citation: Mol Cell Proteomics. 2006 Apr;5(4):573-88
references.pmid: 16332733
references.citation: Nature. 2008 Apr 3;452(7187):571-9
references.pmid: 18385731
references.citation: J Proteome Res. 2007 Mar;6(3):967-75
references.pmid: 17330939
references.citation: Trends Pharmacol Sci. 2006 May;27(5):251-9
references.pmid: 16600386
references.citation: Cancer Lett. 2006 Sep 8;241(1):49-58
references.pmid: 16298039
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Aug;855(1):14-20
references.pmid: 17161666
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 25;813(1-2):1-26
references.pmid: 15556511
references.citation: Mol Cell Proteomics. 2005 Oct;4(10):1487-502
references.pmid: 15979981
references.citation: Mol Cell Proteomics. 2007 Nov;6(11):1997-2011
references.pmid: 17656355
references.citation: Lung Cancer. 2006 Oct;54(1):95-102
references.pmid: 16890323
references.citation: Proteomics. 2006 Jul;6(13):3739-53
references.pmid: 16739131
references.citation: Expert Rev Anticancer Ther. 2007 Aug;7(8):1105-15
references.pmid: 18028019
references.citation: Scand J Gastroenterol. 2004 Apr;39(4):380-4
references.pmid: 15125471
references.citation: Nature. 2003 Oct 30;425(6961):905
references.pmid: 14586448
references.citation: Proteomics. 2006 Nov;6(22):6107-16
references.pmid: 17051643
references.citation: Proteomics. 2005 Aug;5(13):3226-45
references.pmid: 16104056
references.citation: J Proteome Res. 2007 Aug;6(8):2993-3002
references.pmid: 17608509
references.citation: Mol Cell Proteomics. 2004 Dec;3(12):1154-69
references.pmid: 15385600
references.citation: Electrophoresis. 2005 Jul;26(14):2779-85
references.pmid: 15966010
references.citation: Oncogene. 2006 Dec 7;25(58):7650-61
references.pmid: 17043663
references.citation: Genome Res. 2001 Sep;11(9):1484-502
references.pmid: 11544192
references.citation: Arch Otolaryngol Head Neck Surg. 2007 Sep;133(9):910-8
references.pmid: 17875858
references.citation: Mol Cell Biochem. 2007 Apr;298(1-2):83-92
references.pmid: 17109077
references.citation: Nat Biotechnol. 1999 Oct;17(10):994-9
references.pmid: 10504701
references.citation: Breast Cancer Res Treat. 2003 Jul;80(1):87-97
references.pmid: 12889602
references.citation: Curr Probl Cancer. 2002 Jul-Aug;26(4):176-275
references.pmid: 12399802
references.citation: Nat Rev Cancer. 2003 Apr;3(4):243-52
references.pmid: 12671663
references.citation: Proteomics. 2003 Oct;3(10):1980-7
references.pmid: 14625860
references.citation: Expert Rev Proteomics. 2007 Feb;4(1):51-65
references.pmid: 17288515
references.citation: Cancer Immunol Immunother. 2009 Feb;58(2):247-58
references.pmid: 18618111
references.citation: Anticancer Res. 2007 May-Jun;27(3A):1247-55
references.pmid: 17593616
references.citation: Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3410-5
references.pmid: 12624183
references.citation: Eur J Cancer. 2001 Dec;37(18):2405-12
references.pmid: 11720835
references.citation: Anal Bioanal Chem. 2005 Jun;382(3):669-78
references.pmid: 15900442
references.citation: Clin Chem. 2007 Mar;53(3):429-37
references.pmid: 17259234
references.citation: J Proteome Res. 2008 Aug;7(8):3329-38
references.pmid: 18578523
references.citation: Technol Cancer Res Treat. 2008 Jun;7(3):155-60
references.pmid: 18473487
references.citation: J Urol. 1999 Dec;162(6):1930-3
references.pmid: 10569540
references.citation: Mol Cell Proteomics. 2006 Jan;5(1):157-71
references.pmid: 16215274
references.citation: J Proteome Res. 2008 Aug;7(8):3525-34
references.pmid: 18630974
references.citation: J Proteome Res. 2007 Jul;6(7):2802-11
references.pmid: 17539671
references.citation: Nat Rev Cancer. 2005 Nov;5(11):845-56
references.pmid: 16239904
references.citation: J Proteome Res. 2005 Jul-Aug;4(4):1442-50
references.pmid: 16083298
references.citation: Biotechniques. 2002 Apr;32(4):898, 900, 902 passim
references.pmid: 11962611
references.citation: Proteomics. 2005 Jul;5(10):2656-64
references.pmid: 15924293
references.citation: Best Pract Res Clin Obstet Gynaecol. 2002 Aug;16(4):469-82
references.pmid: 12413929
references.citation: J Proteomics. 2008 Apr 30;71(1):19-33
references.pmid: 18541471
references.citation: Proteomics. 2005 Aug;5(12):3173-82
references.pmid: 16035111
references.citation: Med Oncol. 2008;25(4):380-6
references.pmid: 18300004
references.citation: J Eval Clin Pract. 2008 Apr;14(2):275-80
references.pmid: 18284517
references.citation: Proteomics. 2004 May;4(5):1324-34
references.pmid: 15188399
references.citation: Brief Funct Genomic Proteomic. 2004 Nov;3(3):220-39
references.pmid: 15642186
references.citation: Proteomics. 2007 Dec;7(24):4589-600
references.pmid: 18022937
references.citation: FASEB J. 2005 Jul;19(9):1125-7
references.pmid: 15985535
references.citation: Ai Zheng. 2006 Nov;25(11):1361-7
references.pmid: 17094902